Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.

 

Participants will learn how to:

 

• Accelerate time to market for adenovirus manufacturing

• Design the process for scalability

• Reduce downstream processing time from 3 - 4 days to 1 day

Speakers

Clive Glover, PhD

 

Senior Marketing Manager, Cell & Gene Therapy

Pall Biotech

Biography

Rachel Legmann, PhD

 

Senior Manager, Process Development Services

Pall Biotech

Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

Maximize Speed to Market Flexibility of Single-Use for Gene Therapy Manufacturing

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
December 2021

Case studies of Adeno-Associated Virus (AAV) and Lentivirus (LV) production using adherent and suspension cell culture

Watch